Cart
sales@molnova.com
YYA-021
CAS No. 144217-65-2
YYA-021( YYA 021 | YYA021 )
Catalog No. M11874 CAS No. 144217-65-2
A small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor with IC50 of 9 uM against YTA48P virus with no significant cytotoxicity.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
| Size | Price / USD | Stock | Quantity |
| 1 mL x 10 mM in DMSO | 28 | In Stock |
|
| 10MG | 29 | In Stock |
|
| 25MG | 62 | In Stock |
|
| 50MG | 84 | In Stock |
|
| 100MG | 109 | In Stock |
|
| 200MG | 161 | In Stock |
|
| 500MG | Get Quote | In Stock |
|
| 1G | Get Quote | In Stock |
|
Biological Information
-
Product NameYYA-021
-
NoteResearch use only, not for human use.
-
Brief DescriptionA small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor with IC50 of 9 uM against YTA48P virus with no significant cytotoxicity.
-
DescriptionA small-molecule CD4 mimic that acts as a highly potent HIV entry inhibitor with IC50 of 9 uM against YTA48P virus with no significant cytotoxicity; shows wide tissue distribution and relatively high distribution volumes, and has promise for intravenous administration.
-
In Vitro——
-
In Vivo——
-
SynonymsYYA 021 | YYA021
-
PathwayMicrobiology/Virology
-
TargetHIV
-
RecptorGp120
-
Research AreaInfection
-
Indication——
Chemical Information
-
CAS Number144217-65-2
-
Formula Weight317.4259
-
Molecular FormulaC18H27N3O2
-
Purity>98% (HPLC)
-
Solubility10 mM in DMSO
-
SMILESO=C(NC1CC(C)(C)NC(C)(C)C1)C(NC2=CC=C(C)C=C2)=O
-
Chemical NameEthanediamide, N1-(4-methylphenyl)-N2-(2,2,6,6-tetramethyl-4-piperidinyl)-
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1. Hashimoto C, et al. Bioorg Med Chem. 2013 Dec 15;21(24):7884-9.
2. Otsuki H, et al. J Gen Virol. 2013 Dec;94(Pt 12):2710-6.
3. Narumi T, et al. Bioorg Med Chem. 2013 May 1;21(9):2518-26.
molnova catalog
related products
-
Rilpivirine
A highly potent nonnucleoside inhibitor (NNRTI) of HIV-1 reverse trK7912:M7912anscriptase with IC50 of 0.4 nM for WT HIV-1 in cell-based assay.
-
GSK-2838232
GSK-2838232 is a novel HIV maturation inhibitor being developed for the treatment of HIV in combination with other antiretroviral therapy.
-
Doravirine
Doravirine (MK-1439, MK1439) is a novel, highly specific HIV-1 nonnucleoside reverse transcriptase inhibitor (NNRTI) with IC50 of 12, 9.7, and 9.7 nM against WT, K103N, and Y181C reverse transcriptase (RT) mutants, respectively.
